吉非替尼加白介素2治疗既往化疗过的晚期非小细胞肺癌患者已有研究证明通过吉非替尼治疗可活化淋巴细胞在这个Ⅱ期预试验中，作者探索IL-2和吉非替尼在非小细胞肺癌(NSCLC)治疗时潜在的协同作用从2003年9月到2006年11月，70连续收治的既往化疗过的晚期、渐进性NSCLC患者，接受了吉非替尼口服250mg qd山东省肿瘤医院呼吸肿瘤内科张品良最初39例患者...

Discussion讨论Treatment Approaches治疗手段Targeted Therapies 靶向治疗Ceritinib 色瑞替尼Ceritinib is approved by the FDA for patients with ALK-positive metastatic NSCLC who have progressed on or ...

EMERGING TARGETED AGENTS FOR PATIENTS WITH GENETIC ALTERATIONS具有遗传学改变患者的新兴靶向药物山东省肿瘤医院呼吸肿瘤内科张品良

OverviewThe American Cancer Society estimates that 234,190 Americans will be diagnosed with invasive breast cancer and 40,730 will die of the disease in the United States in 2015  ...

机械装置——癌症相关的静脉血栓栓塞症（NCCN 2014V2） 间歇充气压力泵(IPC)IPC装置的主要优势之一是没有相关的出血风险但是，缺点包括可能妨害走动并且需要保持该装置在适当位置差不多持续到患者完全不卧床为止分级加压弹力袜(GCS)作为一个物理预防手段可联合使用IPC装置山东省肿瘤医院呼吸肿瘤内科张品良腔静脉滤器腔静脉滤器适用于由于对治疗性抗凝绝对禁...

CHEMOTHERAPY REGIMENS FOR RECURRENT OR METASTATIC BREAST CANCERPreferred single agents:Anthracyclines●Doxorubicin●Pegylated liposomal doxorubicinTaxanes●Paclitaxel Anti-metabolites...

NSCLC NCCN2016V4 PRINCIPLES OF DIAGNOSTIC EVALUATION 诊断评估原则* Patients with a strong clinical suspicion of stage I or II lung cancer (based on risk factors and radiologic appearanc...

Adjuvant Treatment 辅助治疗Chemotherapy or Chemoradiation 化疗或放化疗Post-surgical treatment options for patients with stage IA tumors (T1ab, N0) and with positive surgical margins (R1, R2)...

NCCN Guidelines Version 32017 NCCN指南2017第3版Non-Small Cell Lung Cancer 非小细胞肺癌山东省肿瘤医院呼吸肿瘤内科张品良Discussion 讨论Staging 分期A new edition of the AJCC Cancer Staging Manual (8th edition) wa...

Cancer-Associated Venous Thromboembolic Disease Version 12016癌症相关静脉血栓栓塞症2016年第1版山东省肿瘤医院呼吸肿瘤内科张品良Updates in Version 12016 of the NCCN Guidelines for Cancer-Associated Venous Thrombo...